Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nerve Growth Factor”

365 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 365 results

Testing effectiveness (Phase 2)Study completedNCT01164007
What this trial is testing

Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 40
Not applicableNot Yet RecruitingNCT06638008
What this trial is testing

Ultrasound Guided Placental Growth Factor Vs Platelet Rich Plasma Injection in Peripheral Nerve Injury: an Interventional Study

Who this might be right for
Peripheral Nerve Injury Upper Limb
Assiut University 75
Not applicableNo Longer AvailableNCT04681118
What this trial is testing

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Brainstorm-Cell Therapeutics
Early research (Phase 1)Ended earlyNCT07121829
What this trial is testing

Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorPilocytic Astrocytoma+7 more
Day One Biopharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Early research (Phase 1)Study completedNCT00006488
What this trial is testing

Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease
National Center for Research Resources (NCRR)
Large-scale testing (Phase 3)Ended earlyNCT03419403
What this trial is testing

UNITE Study: Understanding New Interventions With GBM ThErapy

Who this might be right for
Glioblastoma Multiforme
AbbVie 40
Early research (Phase 1)Study completedNCT00844064
What this trial is testing

Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2

Who this might be right for
Pancreatic NeoplasmsMelanomaColorectal Neoplasms
Isarna Therapeutics GmbH 62
Not applicableStudy completedNCT06166095
What this trial is testing

Dose-Response Effect Exercise and Depression

Who this might be right for
Depression
University of Central Florida 48
Not applicableActive Not RecruitingNCT07189130
What this trial is testing

The Acute Effect of Different Resistance Exercise Loads on Irisin and Brain-derived Neurotrophic Factor in Blood Serum and Plasma

Who this might be right for
BDNFIrisinResistance Exercise+3 more
University of Ljubljana 24
Not applicableUnknownNCT06563193
What this trial is testing

Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study

Who this might be right for
Overactive Bladder
Erzincan Binali Yildirim Universitesi 44
Not applicableNot Yet RecruitingNCT06677034
What this trial is testing

Effects of Exercise on Functional Performance, BDNF, Executive Functions and Sleep Quality in Children with Epilepsy

Who this might be right for
Epilepsy
Inonu University 50
Early research (Phase 1)WithdrawnNCT01941849
What this trial is testing

Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma

Who this might be right for
PhaeochromocytomaParaganglioma
University College, London
Post-approval studies (Phase 4)Ended earlyNCT02969876
What this trial is testing

Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine

Who this might be right for
Depressive DisorderMajor DepressionDepression+1 more
Massachusetts General Hospital 2
Not applicableUnknownNCT04495192
What this trial is testing

Predictors of Better Outcomes After Severe Acquired Brain Injuries

Who this might be right for
Brain InjuriesDisorder of Consciousness
Fondazione Don Carlo Gnocchi ETS 520
Large-scale testing (Phase 3)Study completedNCT00830063
What this trial is testing

Tanezumab In Osteoarthritis Of The Knee (2)

Who this might be right for
ArthritisOsteoarthritis
Pfizer 832
Large-scale testing (Phase 3)Study completedNCT03172299
What this trial is testing

Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated with Proton Therapy for a Large Choroidal Melanoma

Who this might be right for
Ocular Melanoma
Centre Hospitalier Universitaire de Nice 57
Post-approval studies (Phase 4)Study completedNCT01093534
What this trial is testing

Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.

Who this might be right for
Detrusor OveractivityOveractive Bladder
Astellas Pharma Inc 547
Not applicableStudy completedNCT01492309
What this trial is testing

Beat the Blues in Pregnancy Study - Transcranial Magnetic Stimulation

Who this might be right for
Major Depressive Disorder
University of Pennsylvania 22
Not applicableUnknownNCT06267066
What this trial is testing

Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus

Who this might be right for
Lichen Simplex Chronicus
Cairo University 60
Next Page